Preclinical findings suggest BPC-157 may support the fibrocartilaginous transitional zone critical to rotator cuff repair, though human clinical evidence is not yet available
Dasatinib is a classical anticancer drug, a tyrosine kinase inhibitor, which also exhibits senolytic effects [114]

BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
/sc-assets/prd/practices/86fdffc1-7171-4481-9165-a61d4ecbb3fd/NL%20logo%203.jpg)
Acknowledgements SSG thanks Symbiosis International (Deemed University) for the award of a junior research fellowship
We note that the resident-to-bed ratio cap is a cap on the resident-to-bed ratio calculated for all residents, including allopathic, osteopathic, dental, and podiatry residents (63 FR 26324, May 12, 1998)